GHK-Cu is oriented toward extracellular matrix quality and repair
Lombard, D
Do peptides require a prescription
In small double-blind crossover trials at a single UK centre, an intravenous kisspeptin-54 infusion modulated sexual brain-processing networks on fMRI and increased penile tumescence by up to 56% versus placebo in men with HSDD (Mills et al., JAMA Netw Open 2023), with parallel brain-processing findings reported in women with HSDD (Thurston et al., 2022) and in healthy men (Comninos et al., 2017)
reports interests in Ropirio Therapeutics, Earli Inc., Sunbird Bio, Satellite Bio, Catalio Capital, Port Therapeutics, Matrisome Bio, Xilio Therapeutics, Ochre Bio, Impilo Therapeutics, Vertex Pharmaceuticals, Moderna, Johnson & Johnson and Owlstone, which were not involved in this study
Research peptides do not fall under the same drug approval framework as traditional pharmaceuticals, meaning GHK-Cu products cannot make therapeutic claims and are sold for research purposes only
